Sf9, Baculovirus cells.
HDAC8 Human Recombinant produced in Sf9 Baculovirus cells, glycosylated polypeptide chain containing 383 amino acids (1-377) and having a molecular mass of 42.6kDa. HDAC8 is fused to a 6 amino acid His-tag at C-terminus & purified by proprietary chromatographic techniques.
Sf9, Baculovirus cells.
Histone deacetylase 8 (HDAC8) is a member of the class I histone deacetylases (HDACs), which are crucial enzymes involved in the transcriptional regulation of gene expression in eukaryotic cells . HDACs catalyze the removal of acetyl groups from lysine residues on histones, leading to chromatin condensation and transcriptional repression .
HDAC8 is a 43 kDa protein that is expressed in various tissues and has been shown to play a role in several biological processes . It functions on both histone and non-histone substrates, producing free lysine and acetate by catalyzing the hydrolysis of acetyllysine side chains . HDAC8 is involved in skull morphogenesis and the metabolic control of the ERR-alpha/PGC1-alpha transcriptional complex .
HDAC8 has been implicated in various diseases, particularly cancer. Overexpression and deregulation of HDAC8 contribute to cancer cell proliferation, metastasis, immune evasion, and drug resistance . Additionally, HDAC8 is associated with non-cancer diseases such as Cornelia de Lange Syndrome (CdLS), infectious diseases, cardiovascular diseases, pulmonary diseases, and myopathy .
Given its involvement in multiple diseases, HDAC8 is considered an attractive therapeutic target. Various HDAC8 selective inhibitors (HDAC8is) have been developed, showing promising anti-cancer effects . These inhibitors aim to restore normal acetylation levels, thereby reversing the pathological phenotypes associated with HDAC8 deregulation .